Led · Equity · Oct 2022

Isthara provides shared-living accommodation for working professionals and students, pairing a host of amenities with premium features. Led by Gilbert James and Krishna Kumar, the company has also grown in the B2B institutional cafeteria segment. It intends to build on its B2C portfolio and scale operations across the retail food court market by launching smart food courts in retail locations such as malls. Isthara recently acquired software product engineering firm Letsmobility to introduce advanced tech solutions in the co-living and institutional cafeteria sectors. The company plans to double bed capacity in its co-living and student accommodation segments to around 50,000 beds by 2025. After the latest round, Isthara has raised approximately $21 million to date, and will use the new funding to support these expansion and capacity plans.

Led · Series A · Jul 2022

Priori Legal runs a global Marketplace that matches in-house legal teams with vetted attorneys and a SaaS product, Scout, that manages outside-counsel panels and surfaces firm- and attorney-level insights. Marketplace hosts more than 8,000 attorneys, with lawyers in all 50 U.S. states and 55 countries covering over 700 practice proficiencies, and its Marketplace revenue grew approximately 250% year-over-year. Scout is in beta with customers including Hearst, Marsh McLennan, Zimmer Biomet and a Fortune 10 technology company, and more than 30 law firms (including Orrick and 13 other AmLaw 50 firms) have joined the Scout beta. The company says its platform saves corporate legal teams time and money and supports diversity and hiring goals. Priori plans to expand product functionality, accelerate new product development, scale go-to-market efforts, and substantially grow headcount across sales, marketing, engineering, and operations using the new capital. Priori Legal operates a marketplace of vetted lawyers that runs competitive bidding and streamlines billing and onboarding for companies hiring outside counsel. The company accepts about 10% of applicant lawyers and currently hosts more than 1,500 lawyers across all 50 U.S. states and 47 countries with 700 practice proficiencies. Priori says it saves companies an average of 60% on outside‑counsel spending and reduces search time by 80%; client spending on the platform increased 200% in the last year. Founders Basha Rubin and Mirra Levitt launched the business as a legal marketplace for SMBs before finding its current enterprise model in 2016. Priori does not provide legal services itself and focuses on the process of rapidly identifying talent and making billing seamless. The company plans to use funding to grow the team, expand its international lawyer network, and build out data and machine‑learning capabilities across vetting, matchmaking, bidding and project scoping.

Led · Seed · Nov 2021

Robin is an NYC-based social-emotional learning (SEL) solution that connects students with coaches and curriculum. The platform provides programming and support for educators to engage students' mental health and well-being. Coaches create safe spaces in school for students to open up, provide peer support, and ask for help. Students learn skills to build self-esteem and resilience, process negative emotions and thoughts, and manage stress and anxiety. Coaching can be combined with curriculum, five-minute activities, and meditations to provide continuous skill development and emotional growth throughout the year. Co-founded by Sonny Thadani and Scott Farber, the company closed a $2M seed round to expand operations and broaden its business reach.

Participated · Series C · Oct 2021

ContractPodAi provides an AI-powered contract lifecycle management (CLM) platform branded as the 'One Legal Platform' that handles end-to-end legal lifecycles and integrates with complementary technology providers. The platform leverages IBM Watson and Microsoft Azure and is positioned to support any use-case, document type, or scenario for leading corporations. ContractPodAi was founded in 2012 and is headquartered in London, with global offices in San Francisco, New York, Glasgow, Chicago, Sydney, Mumbai, and Toronto. The company has received several awards and was named a Visionary in the 2021 Gartner Magic Quadrant for Contract Lifecycle Management. In September 2021 ContractPodAi raised $115 million in a Series C to further accelerate platform capabilities and expand its international market presence. Management indicated proceeds will be used to leverage SoftBank's networks to capture growth opportunities in the APAC region. ContractPodAi provides an end-to-end contract lifecycle management platform covering contract generation, a contract repository and third-party review. Its AI capabilities use IBM’s Watson and are intended to streamline contract workflows and reduce burden on corporate in-house legal teams. The company sells a fixed-fee SaaS licence that includes full implementation as part of the annual subscription. Its solution is industry-agnostic but typically targets large international customers, including FTSE 500 and Fortune 2000 companies; customers named include Bosch Siemens, Braskem, EDF Energy, Total Petroleum, Benjamin Moore and Freeview. ContractPodAi was founded in 2012 and is headquartered in London with additional offices in San Francisco, New York, Glasgow and Mumbai. With new capital, the company plans to significantly scale product development, sales and customer success teams globally.

Participated · Equity · Sep 2018

InfoBionic develops the MoMe® ARC platform, a third-generation virtual telemetry system for remote, wireless monitoring and diagnosis of cardiac arrhythmias. Its MoMe® ARC 4-in-1 monitor pairs a 3rd-generation remote ECG device with a Bluetooth diagnostic 6-lead sensor and offers both patch-type and wire-based sensors. The system delivers heartbeat-to-heartbeat, full-disclosure ECG data over the cloud to provide near real-time, hospital telemetry-level access for clinicians. The company recently received FDA approval for the third-generation MoMe® ARC platform. InfoBionic plans to use the Series D proceeds to continue commercial expansion of the MoMe® ARC system. The company is led by CEO Stuart Long. InfoBionic develops the MoMe® Kardia remote cardiac monitoring platform that provides physicians 24/7 on-demand access to full-disclosure Holter, Event, and MCT data via a HIPAA-compliant portal. The system is positioned to replicate in-hospital telemetry data in the outpatient setting and was granted FDA 510(k) clearance in 2015. The company targets an addressable U.S. market estimated at $1.4 billion and recently announced a commercial distribution partnership to enhance market penetration. InfoBionic reports month-to-month subscription growth rates exceeding 35% since this time last year. The completed financing is intended to support continued commercial expansion of the MoMe® Kardia system. InfoBionic develops the MoMe® Kardia system, a cloud-based remote patient monitoring platform for cardiac arrhythmia detection. The platform streams continuous electrocardiogram, respiration and motion data to the cloud for analysis and delivers automated reporting to mobile devices, tablets and web portals. It provides on-demand, actionable monitoring data and analytics for Holter, Event and mobile cardiac telemetry (MCT) directly to physicians. The company is led by Nancy Briefs, President, CEO and Co-Founder. InfoBionic raised a financing round to support commercialization of the MoMe® Kardia system. The articles report the company is based in Lowell, Massachusetts. InfoBionic is an emerging digital health company focused on providing anywhere, anytime access to cardiac event monitoring with improved event detection and clinical efficacy through a lower-cost business model. Its lead product, the MoMe System, is a cloud-based, multi-pass analysis universal remote patient monitoring platform that provides seamless transition between Holter, Event, and Mobile Cardiac Telemetry monitoring modes in one device. MoMe Kardia is positioned to address the roughly $3B worldwide cardiac monitoring market by delivering enhanced analytics and on-demand access to patient data for diagnosis. Proceeds from the recently closed Series B tranche will enable commercialization of the MoMe System in Europe and the United States. The company emphasizes cloud technology to improve patient monitoring, diagnosis and treatment while reducing operating and healthcare costs. Safeguard Scientifics’ participation and board representation signal strategic support for commercialization and growth.